# T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010

> **NCT03022396** · PHASE4 · COMPLETED · sponsor: **Stanford University** · enrollment: 82 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** High Dose Fluzone® (intramuscular)
- **BIOLOGICAL:** Fluzone® (intramuscular)

## Key facts

- **NCT ID:** NCT03022396
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2017-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03022396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03022396, "T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03022396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*